A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. - Wikidata - wikimedia - TriplyDB

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

http://www.wikidata.org/entity/Q33864621

about

A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor An analysis of vertebrate mRNA sequences: intimations of translational control A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2.Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization Regulation of serum amyloid A protein expression during the acute-phase response Early immune responses accompanying human asymptomatic Ebola infections A naturally occurring soluble isoform of murine Fas generated by alternative splicing Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.Molecular cloning, expression and characterization of ovine TNF alpha.Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.Tumor necrosis factor-alpha regulates secretion of the adipocyte-derived cytokine, leptin.Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.Cytokine polymorphisms in systemic lupus erythematosus and Sjögren's syndrome.Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS.Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study.Regulation of tumour necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection.Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.Shedding of TNFR1 in regenerative liver can be induced with TNF alpha and PMA Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation.Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.C-terminal truncated forms of Met, the hepatocyte growth factor receptor Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo Soluble tumor necrosis factor receptor mediates cell proliferation on lipopolysaccharide-stimulated cultured human decidual stromal cells.Association of malaria-induced murine pregnancy failure with robust peripheral and placental cytokine responses.Cytokine receptors of the lung.Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.Circulating soluble cytokine receptors and colorectal cancer risk.Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

P2860

Q24537683-C28D338A-A9DE-4A85-853D-E4D84BD3BA9F Q24562055-37EBC985-EA73-444D-9B80-5FCD6232650A Q24642530-5402EB42-2336-4842-A108-1E10E2A71AEA Q24675629-8F944139-3CF3-4A58-A8E9-A9B88791DD8C Q24811065-27615157-9A91-43B7-887D-18CB6E0B0A12 Q24812785-5E7F2A82-144A-4B13-BA4B-C2A3F0EB2E88 Q28117974-DE6811C3-44C1-4A60-A19F-98F19BC22598 Q28281545-A5AC3C56-A0BC-444B-86D1-90DCB6F8B05E Q28344889-CD23D7DD-4A5F-4A01-B2EA-636A4F26CB54 Q28505798-674FA73D-D002-4CF6-B79F-3E730750E249 Q30443950-D80AD82C-F27D-45A3-BD79-EC56164312BA Q30834362-6F78896B-C0C6-4012-893F-F4ADADBE747E Q33641577-776FD5BB-430D-43D6-B31C-0772D76C6E1E Q33782360-4FF6C0AB-3D39-45EA-9C2B-65EEBE8143B1 Q33937497-570B6D14-BACE-48E0-BB52-6821B340BBC3 Q33966320-F6EB8272-EE39-4810-B75B-A9516A9AEE85 Q34071248-76BAAB72-6F15-4F97-9B42-A4BE5E4A98FC Q34224994-1B9DAB52-3739-453B-8B9F-446B8DC8E22F Q34299851-944361A8-D843-4D34-ABAD-A7897279BFD1 Q35054688-DE87EB04-5C4C-410A-A6A6-C7D2E94B7C9F Q35220307-51EA9FDA-650F-4EFC-ABD9-B1D60DC60E09 Q35231318-28C30E18-18C6-4005-A80C-54F35744CAAA Q35355967-808791CF-4A46-4368-9676-85371D04802F Q35356446-5D6F11EA-C16F-4BB9-BB58-6AC0329707AB Q35796182-FE5669F8-691A-41A0-B241-440C85B4FBBA Q36080342-5AA2F9C1-F13F-4B73-AFE3-68B2A5CB3662 Q36135454-B18F9583-9E64-4B2B-8EAD-6686AD0F3DEB Q36308436-BB6A94B1-9585-4FA5-9CD2-6FAEFC409698 Q36361402-1B09AAE9-A5F4-4B7D-A6C1-5305CB26E3E7 Q36470890-4BD340EF-95BD-48F3-AFD7-2E59E4D8549A Q36565477-A290B049-D4DB-43F9-AF2B-03863DED1735 Q36728560-7027EAC2-2290-46EE-A63E-0FB7017495C4 Q36743037-83D7CE3F-FB68-463C-B006-256582108887 Q37031936-477086F5-E413-4D75-9E6E-20553492F8ED Q37224669-8CE6A07F-9260-40CF-81D7-8AE68E1A804D Q37410377-FBAB89E9-0CF6-42DA-B439-D29316DE5950 Q37421913-47322468-F49F-4C32-BED5-FE41EA7BB7B9 Q37599410-BD6F6AB5-500D-4439-B3C2-D5F753511B74 Q37625918-C7B9F3B3-F84C-4D73-9483-5A954569804D Q37629829-2D1A9773-8A07-45FD-A496-E5060BA0BEF3

P2860

A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

http://www.wikidata.org/entity/Q33864621

description

1990 nî lūn-bûn

@nan

1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@ast

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@en

type

label

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@ast

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@en

prefLabel

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@ast

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@en

P1433

Q33864621-77FEAF07-E4F3-47CD-8DC1-542A664B4059

P1476

Q33864621-946388FE-F411-4B6C-8118-35C27826767C

P2093

Q33864621-01222A12-9F51-43DE-9E09-2E5FFC10C513

Q33864621-2074266B-EB0C-422C-AEA7-A68B669D4AB8

Q33864621-445CC6F6-4011-46A4-A850-842B2FC10D60

Q33864621-647693DA-9FF2-4184-BE18-8AC8C75F698F

Q33864621-67EC5E24-0364-44DB-B2FB-FFD7123E0C6E

Q33864621-83A8F49B-7B84-4833-B7A4-DDE51E5C9ED8

Q33864621-8BA986B5-8B9B-4C95-A879-1F35D47D0316

Q33864621-E5004B79-5F89-440B-8AA6-BF71EB03FB53

Q33864621-F86CE41F-E69D-4D56-AA40-00F21615E0BD

P2860

Q33864621-083DA874-26DE-4ABB-8E72-55B76258956D

Q33864621-0D4C8807-5CDB-47E2-A07B-EC3594614C1B

Q33864621-213AD225-5F56-46D3-B3DE-FC2610FF4A18

Q33864621-3C76BA98-F004-483C-8897-7A1091D795D8

Q33864621-4F455F35-5E53-48EA-8073-4495667E96E9

Q33864621-637C45A4-54E2-49BE-A718-84135EFDB93A

Q33864621-64806A4F-7101-4FB5-BCB5-C57004ADE764

Q33864621-6FCFE5AD-74ED-43B3-A3CE-0433C36D41CD

Q33864621-6FD143C8-1035-4C38-BC0F-57464BE13A73

Q33864621-70C63CCB-6D66-4398-8FE1-EC12D4078875

P304

Q33864621-0661D0B2-4A35-4AA8-8417-E313868E1AE4

P31

Q33864621-04A3EC26-A9C4-4A53-A912-D26719F05BE3

P356

Q33864621-137EE78E-D2F3-40D2-8B5A-5CDCE1FCEDD0

P407

Q33864621-22F39394-AB8B-429D-9534-BBC5DF5E6818

P433

Q33864621-383F09E4-9A98-4070-A08D-018F5D1874FF

P478

Q33864621-E044EF23-6783-4F00-AF00-E4F7ADD8A85A

P577

Q33864621-286DE225-BCEF-45D3-AAFD-BF9C1A4D8F7B

P5875

Q33864621-D94A3C42-0B6D-48F3-933D-806164780291

P698

Q33864621-C281026A-00A9-4564-BA78-1E12D8936A8F

P932

Q33864621-07E9A145-70BE-44F5-9B5F-C6CAE6AAD588

P356

PNAS.87.21.8331

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A second tumor necrosis factor ...... mor necrosis factor inhibitor.

@en

P2093

Baker SL

http://www.w3.org/2001/XMLSchema#string

Brewer MT

http://www.w3.org/2001/XMLSchema#string

Hale KK

http://www.w3.org/2001/XMLSchema#string

King MW

http://www.w3.org/2001/XMLSchema#string

Kohno T

http://www.w3.org/2001/XMLSchema#string

Schwartz PE

http://www.w3.org/2001/XMLSchema#string

Squires CH

http://www.w3.org/2001/XMLSchema#string

Thompson RC

http://www.w3.org/2001/XMLSchema#string

Vannice JL

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Human tumor necrosis factor-alpha receptor. Purification by immunoaffinity chromatography and initial characterization

Expression and structure of the human NGF receptor

Molecular cloning and expression of a receptor for human tumor necrosis factor

Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

P304

8331-8335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.87.21.8331

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1990-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20983039

http://www.w3.org/2001/XMLSchema#string

P698

2172983

http://www.w3.org/2001/XMLSchema#string

P932

54949

http://www.w3.org/2001/XMLSchema#string